New logo with tagline.jpg
Vaxcyte Appoints John Furey to Board of Directors
July 02, 2024 08:30 ET | Vaxcyte, Inc.
Vaxcyte appoints John Furey to Board of Directors.
22157.jpg
Global Vaccine Partnering Deals Analysis Report and Directory 2016-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area
June 25, 2024 11:22 ET | Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Vaccine Collaboration and Licensing...
astrivax_high resolution.png
AstriVax enters clinical phase with its novel vaccine platform technology
June 24, 2024 01:00 ET | AstriVax
The first participants have been dosed in SAFYR, a Phase I clinical trial to test the safety and efficacy of two prophylactic vaccines developed with AstriVax technology.  The study will also provide...
Vaccine Contract Manufacturing Market
Vaccine Contract Manufacturing Market Report 2024-2030: Discover the Trends and Drivers Shaping the Global Landscape
June 17, 2024 04:20 ET | Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Vaccines Market
Global Vaccines (Monovalent, Multivalent) Market Research Report 2024-2028: $94.9 Billion Market Analysis by Technology, Disease, Route of Administration
June 05, 2024 04:25 ET | Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease...
Global Anti-Venom Market
Global Anti-Venom Market Report 2024-2032, by Species, Anti-venom Type, Mode of Action, End User and Region - A $2 Billion Market by 2032
June 04, 2024 12:37 ET | Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-Venom Market Report by Species, Anti-venom Type, Mode of Action, End User, and Region 2024-2032" report has been added to ...
22157.jpg
Allergy Vaccine Market Trends, Forecast and Competitive Analysis: A $3.6 Billion Market by 2030 with a CAGR of 7.5% from 2024 to 2030
May 31, 2024 04:18 ET | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
22157.jpg
Meningococcal Vaccines Analysis Report 2024: A $3.1 Billion Market by 2024 - Simplifying Regulatory Procedures to Accelerate Vaccine R&D
May 29, 2024 04:14 ET | Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Meningococcal Vaccines Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.Meningococcal Vaccines Market will surpass...
Global Vaccine Delivery Devices Market
Global Vaccine Delivery Devices Market Analysis & Forecast 2024-2034
May 27, 2024 04:01 ET | Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Delivery Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Dyadic Logo Current.jpg
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 14, 2024 16:00 ET | Dyadic International, Inc.
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant...